logo
  

ANI Pharmaceuticals, Inc. Q1 Profit Increases, Beats Estimates

ANI Pharmaceuticals, Inc. (ANIP) announced a profit for its first quarter that increased from last year and beat the Street estimates.

The company's earnings totaled $17.801 million, or $0.82 per share. This compares with $1.033 million, or $0.06 per share, in last year's first quarter.

Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $23.466 million or $1.21 per share for the period.

Analysts on average had expected the company to earn $1 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 28.7% to $137.430 million from $106.786 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance (GAAP) :

-Earnings (Q1): $17.801 Mln. vs. $1.033 Mln. last year.
-EPS (Q1): $0.82 vs. $0.06 last year.
-Revenue (Q1): $137.430 Mln vs. $106.786 Mln last year.

-Guidance:
Full year EPS guidance: $4.26 to $4.67
Full year revenue guidance: $520 to $542 Mln

For comments and feedback contact: editorial@rttnews.com

Minutes of the latest Fed policy session dominated the economics scene this week. Find out what made policymakers give a “higher for longer” signal on interest rates. In Europe, the main news out this week was the inflation print from the U.K. Learn how the data was bad news for those hoping for an imminent rate cut from the Bank of England. Also, explore why New Zealand's central bank also hinted at a delay in its plans for interest rate reduction in future.

View More Videos
Follow RTT